Literature DB >> 7734203

Genetic polymorphisms in xenobiotic metabolism.

C A Smith1, G Smith, C R Wolf.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7734203     DOI： 10.1016/0959-8049(94)00382-f

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN： 0959-8049            Impact factor:   9.162


× No keyword cloud information.
  22 in total

1.  Sexual dimorphism in xenobiotic genetic variants-mediated risk for Parkinson's disease.

Authors:  Nadella Kumudini; Addepally Uma; Shaik Mohammad Naushad; Rukmini Mridula; Rupam Borgohain; Vijay Kumar Kutala
Journal:  Neurol Sci       Date:  2014-01-04       Impact factor: 3.307

2.  Genetic variations in xenobiotic metabolic pathway genes, personal hair dye use, and risk of non-Hodgkin lymphoma.

Authors:  Yawei Zhang; Kathryn J Hughes; Shelia Hoar Zahm; Yaqun Zhang; Theodore R Holford; Li Dai; Yana Bai; Xuesong Han; Qin Qin; Qing Lan; Nathaniel Rothman; Yong Zhu; Brian Leaderer; Tongzhang Zheng
Journal:  Am J Epidemiol       Date:  2009-10-12       Impact factor: 4.897

3.  Association between the CYP1A2 polymorphisms and risk of cancer: a meta-analysis.

Authors:  Wen-Xia Sun; Ying-Hua Chen; Zhi-Zhong Liu; Jian-Jun Xie; Wei Wang; Ya-Ping Du; Yu Chen; Xu-Liang Shen; Xiao-Feng He; Li-Xia Wu; Wu Wei; Lin Zhang
Journal:  Mol Genet Genomics       Date:  2014-12-04       Impact factor: 3.291

4.  Suboptimal cotrimoxazole prophylactic concentrations in HIV-infected children according to the WHO guidelines.

Authors:  Claire Pressiat; Veronique Mea-Assande; Caroline Yonaba; Jean-Marc Treluyer; Désiré-Lucien Dahourou; Madeleine Amorissani-Folquet; Stéphane Blanche; François Eboua; Diarra Ye; Gabrielle Lui; Karen Malateste; Yi Zheng; Valeriane Leroy; Déborah Hirt
Journal:  Br J Clin Pharmacol       Date:  2017-09-20       Impact factor: 4.335

5.  Influence of NAT2 polymorphisms on sulfamethoxazole pharmacokinetics in renal transplant recipients.

Authors:  Hideaki Kagaya; Masatomo Miura; Takenori Niioka; Mitsuru Saito; Kazuyuki Numakura; Tomonori Habuchi; Shigeru Satoh
Journal:  Antimicrob Agents Chemother       Date:  2011-11-21       Impact factor: 5.191

Review 6.  Genes, oxidative stress, and the risk of chronic obstructive pulmonary disease.

Authors:  H Koyama; D M Geddes
Journal:  Thorax       Date:  1998-08       Impact factor: 9.139

7.  NAT2 and CYP1A2 phenotyping with caffeine: head-to-head comparison of AFMU vs. AAMU in the urine metabolite ratios.

Authors:  A Nyéki; T Buclin; J Biollaz; L A Decosterd
Journal:  Br J Clin Pharmacol       Date:  2003-01       Impact factor: 4.335

8.  Association of NAT2 phenotype with risk of head and neck carcinoma: A meta-analysis.

Authors:  Youyang Zheng; Yong Li; Yaoshu Teng; Zhen Zhang; Xiaolin Cao
Journal:  Oncol Lett       Date:  2011-11-24       Impact factor: 2.967

Review 9.  Phase I and II enzyme polymorphisms as risk factors for Barrett's esophagus and esophageal adenocarcinoma: a systematic review and meta-analysis.

Authors:  L M Bull; D L White; M Bray; Z Nurgalieva; H B El-Serag
Journal:  Dis Esophagus       Date:  2009-02-13       Impact factor: 3.429

10.  Genetic polymorphism of N-acetyltransferase-2, glutathione S-transferase-M1, and cytochromes P450IIE1 and P450IID6 in the susceptibility to head and neck cancer.

Authors:  M V González; V Alvarez; M F Pello; M J Menéndez; C Suárez; E Coto
Journal:  J Clin Pathol       Date:  1998-04       Impact factor: 3.411
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.